BRONTE CAPITAL MANAGEMENT PTY LTD. – Merrimack Pharmaceuticals, Inc. Transaction History
BRONTE CAPITAL MANAGEMENT PTY LTD. portfolio value:
$0
portfolio value
BRONTE CAPITAL MANAGEMENT PTY LTD. quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -578.31K shares | -3.44M | $3.75 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -217K | $5.95 | 578.31K | |
| Q1 2022 | share | Increase | +7.58% | 40.72K shares | 1.55M | $6.33 | 578.31K |
| Q4 2021 | share | Decrease | -2.05% | -11.25K shares | -549K | $3.93 | 537.58K |
| Q3 2021 | share | 0.00% | 0 shares | -856K | $4.83 | 548.83K | |
| Q2 2021 | share | Decrease | -0.33% | -1.84K shares | 49K | $6.39 | 548.83K |
| Q1 2021 | share | Increase | +3.61% | 19.16K shares | -204K | $6.28 | 550.67K |
| Q4 2020 | share | 0.00% | 0 shares | 1.61M | $6.89 | 531.51K | |
| Q3 2020 | share | Increase | 0.00% | 531.51K shares | 2.05M | $4 | 531.51K |